Based on the impaired metabolic function and more severe inflammation in the NOD2−/− mice the conclusion is that NOD2 signaling is protective against metabolic disease [83,85] and this protection requires Rip2k signaling [85]. This evidence concerns the gene NOD2 and Other metabolic disease.